According to Radiology Business, experts are raising significant concerns regarding amyloid-related imaging abnormalities in patients who receive modern monoclonal antibody infusions for Alzheimer's disease treatment.
To properly monitor these patients, experts recommend implementing scheduled MRI brain scans as a necessary precaution during the course of their therapy.